Globus Medical EBITDA Margin 2010-2024 | GMED
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Globus Medical (GMED) over the last 10 years. The current EBITDA margin for Globus Medical as of September 30, 2024 is .
| Globus Medical EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-09-30 | $2.48B | $0.62B | 25.04% |
| 2024-06-30 | $2.24B | $0.50B | 22.16% |
| 2024-03-31 | $1.90B | $0.41B | 21.47% |
| 2023-12-31 | $1.57B | $0.36B | 22.87% |
| 2023-09-30 | $1.23B | $0.29B | 23.55% |
| 2023-06-30 | $1.10B | $0.31B | 28.35% |
| 2023-03-31 | $1.07B | $0.31B | 29.19% |
| 2022-12-31 | $1.02B | $0.30B | 29.52% |
| 2022-09-30 | $1.00B | $0.27B | 26.63% |
| 2022-06-30 | $0.98B | $0.26B | 26.46% |
| 2022-03-31 | $0.96B | $0.24B | 24.74% |
| 2021-12-31 | $0.96B | $0.25B | 25.57% |
| 2021-09-30 | $0.94B | $0.29B | 30.29% |
| 2021-06-30 | $0.93B | $0.28B | 30.20% |
| 2021-03-31 | $0.83B | $0.20B | 24.73% |
| 2020-12-31 | $0.79B | $0.18B | 22.18% |
| 2020-09-30 | $0.77B | $0.16B | 21.22% |
| 2020-06-30 | $0.75B | $0.15B | 20.32% |
| 2020-03-31 | $0.79B | $0.22B | 27.33% |
| 2019-12-31 | $0.79B | $0.22B | 28.37% |
| 2019-09-30 | $0.77B | $0.21B | 27.79% |
| 2019-06-30 | $0.74B | $0.21B | 27.99% |
| 2019-03-31 | $0.72B | $0.21B | 28.57% |
| 2018-12-31 | $0.71B | $0.21B | 29.92% |
| 2018-09-30 | $0.69B | $0.22B | 31.21% |
| 2018-06-30 | $0.68B | $0.21B | 31.70% |
| 2018-03-31 | $0.65B | $0.21B | 32.11% |
| 2017-12-31 | $0.64B | $0.21B | 32.70% |
| 2017-09-30 | $0.61B | $0.21B | 33.82% |
| 2017-06-30 | $0.60B | $0.21B | 34.56% |
| 2017-03-31 | $0.58B | $0.20B | 34.94% |
| 2016-12-31 | $0.56B | $0.20B | 35.28% |
| 2016-09-30 | $0.56B | $0.21B | 36.94% |
| 2016-06-30 | $0.56B | $0.21B | 37.23% |
| 2016-03-31 | $0.55B | $0.21B | 37.07% |
| 2015-12-31 | $0.55B | $0.20B | 36.63% |
| 2015-09-30 | $0.53B | $0.18B | 34.40% |
| 2015-06-30 | $0.51B | $0.18B | 34.31% |
| 2015-03-31 | $0.49B | $0.17B | 34.48% |
| 2014-12-31 | $0.48B | $0.16B | 34.32% |
| 2014-09-30 | $0.46B | $0.16B | 33.62% |
| 2014-06-30 | $0.45B | $0.15B | 33.11% |
| 2014-03-31 | $0.44B | $0.13B | 28.89% |
| 2013-12-31 | $0.43B | $0.12B | 28.57% |
| 2013-09-30 | $0.42B | $0.12B | 28.57% |
| 2013-06-30 | $0.41B | $0.12B | 28.68% |
| 2013-03-31 | $0.40B | $0.14B | 34.01% |
| 2012-12-31 | $0.39B | $0.13B | 34.37% |
| 2012-09-30 | $0.37B | $0.13B | 33.96% |
| 2012-06-30 | $0.36B | $0.13B | 34.71% |
| 2012-03-31 | $0.35B | $0.12B | 34.20% |
| 2011-12-31 | $0.33B | $0.11B | 34.44% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $11.424B | $1.568B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $202.706B | 24.73 |
| Intuitive Surgical (ISRG) | United States | $193.352B | 101.09 |
| Alcon (ALC) | Switzerland | $43.519B | 29.12 |
| Edwards Lifesciences (EW) | United States | $41.599B | 26.42 |
| IQVIA Holdings (IQV) | United States | $36.625B | 20.18 |
| IDEXX Laboratories (IDXX) | United States | $35.273B | 41.54 |
| DexCom (DXCM) | United States | $30.978B | 46.65 |
| Waters (WAT) | United States | $22.985B | 33.99 |
| STERIS (STE) | Ireland | $21.603B | 24.87 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.257B | 0.00 |
| Hologic (HOLX) | United States | $17.928B | 19.36 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.368B | 13.72 |
| Sysmex ADR (SSMXY) | Japan | $13.192B | 41.37 |
| Penumbra (PEN) | United States | $9.397B | 92.04 |
| Masimo (MASI) | United States | $9.192B | 44.48 |
| Teleflex (TFX) | United States | $9.024B | 14.39 |
| Glaukos (GKOS) | United States | $7.669B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.015B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.655B | 26.38 |
| Veracyte (VCYT) | United States | $3.419B | 102.61 |
| Inari Medical (NARI) | United States | $3.051B | 0.00 |
| TransMedics (TMDX) | United States | $2.857B | 90.57 |
| LivaNova (LIVN) | United Kingdom | $2.839B | 16.39 |
| Nihon Kohden (NHNKY) | Japan | $2.480B | 18.84 |
| Elekta AB (EKTAY) | Sweden | $2.209B | 19.86 |
| Tandem Diabetes Care (TNDM) | United States | $2.135B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.897B | 9.91 |
| RxSight (RXST) | United States | $1.848B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.448B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.284B | 0.00 |
| Artivion (AORT) | United States | $1.242B | 82.28 |
| OPKO Health (OPK) | United States | $1.044B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.901B | 15.31 |
| Paragon 28 (FNA) | United States | $0.864B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.738B | 0.00 |
| IRadimed (IRMD) | United States | $0.682B | 36.87 |
| Mesa Laboratories (MLAB) | United States | $0.660B | 15.55 |
| AxoGen (AXGN) | United States | $0.641B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.628B | 0.00 |
| SiBone (SIBN) | United States | $0.561B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.547B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.529B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.503B | 29.61 |
| Tactile Systems Technology (TCMD) | United States | $0.446B | 24.14 |
| Delcath Systems (DCTH) | United States | $0.404B | 0.00 |
| CVRx (CVRX) | United States | $0.377B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.338B | 0.00 |
| NeuroPace (NPCE) | United States | $0.337B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.290B | 0.00 |
| Inogen (INGN) | United States | $0.241B | 0.00 |
| Accuray (ARAY) | United States | $0.216B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.204B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.182B | 0.00 |
| Nevro (NVRO) | United States | $0.160B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.160B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.140B | 15.02 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| 908 Devices (MASS) | United States | $0.100B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.092B | 0.00 |
| LENSAR (LNSR) | United States | $0.088B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.079B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.074B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.073B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.070B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.058B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.056B | 0.00 |
| Envoy Medical (COCH) | United States | $0.046B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.041B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Neuronetics (STIM) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.016B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |